Transvaginal Mesh Trials Begin in December 2013

Report this content

The first bellwether trials in the Transvaginal Mesh MDL (Multidistrict Litigations) are scheduled to start at the end of 2013.

Transvaginal meshes are implantable devices, made by several manufacturers, for the treatment of urinary incontinence and pelvic organ prolapse (POP). Used to support organs in the pelvic region of women, these medical devices have been found to cause painful and dangerous side effects such as erosion, bleeding, infection, and painful sexual intercourse.

According to Legal Newsline, the trials will start Dec. 3 in the U.S. District Court for the Southern District of West Virginia. The defendants in the first three bellwether trials are American Medical Systems (AMS), Boston Scientific, and Ethicon.

The trial of C.R. Bard Inc. in a consolidated case will begin in February. All the federal transvaginal mesh multidistrict litigation trials will be under the supervision of U.S. District Judge Joseph R. Goodwin, writes Legal Newsline.

If you or someone you know has been harmed by an unsafe medical product, contact Sokolove Law today for a free legal consultation and to find out if a product liability lawyer may be able to help you.

Tags: